BeOne Medicines (ONC) Inventory Average (2017 - 2026)

BeOne Medicines (ONC) has 10 years of Inventory Average data on file, last reported at $644.9 million in Q1 2026.

• On a quarterly basis, Inventory Average rose 30.33% year-over-year to $644.9 million in Q1 2026; TTM through Mar 2026 was $644.9 million, a 30.33% increase from a year earlier, with the FY2025 full-year figure at $551.6 million, up 21.08% from the prior year.
• Inventory Average for Q1 2026 stood at $644.9 million, up from $570.0 million in the prior quarter.
• Over the last five years, Inventory Average for ONC reached as high as $644.9 million in Q1 2026 and fell as low as $244.1 million in Q1 2022.
• Historically, Inventory Average has averaged $402.9 million across 5 years, with a median of $431.7 million in 2024.
• Across the five-year window, Inventory Average jumped 200.9% in 2022 and increased 12.01% in 2025, its largest moves.
• Year by year, Inventory Average stood at $286.6 million in 2022, then advanced by 27.87% to $366.5 million in 2023, then climbed by 26.41% to $463.3 million in 2024, then climbed by 23.01% to $570.0 million in 2025, then increased by 13.15% to $644.9 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $644.9 million in Q1 2026, $570.0 million in Q4 2025, and $517.3 million in Q3 2025.